Consonance Capital Management LP - Q4 2022 holdings

Add to watchlist

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
ExitSURROZEN INC*w exp 08/01/203$0–-1,165,832
-100.0%
-2.95%–
ExitSURROZEN INC$0–-3,497,500
-100.0%
-97.05%–
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
UNITED THERAPEUTICS CORP DEL29Q2 202215.9%
ADMA BIOLOGICS INC27Q4 20202.3%
RETROPHIN INC23Q1 202011.3%
ANI PHARMACEUTICALS INC23Q3 20197.9%
VERICEL CORP21Q4 20195.5%
AMARIN CORP PLC14Q3 201914.4%
GLOBUS MED INC13Q2 202224.7%
ORTHOFIX INTL N V13Q3 20169.7%
PACIFIC BIOSCIENCES CALIF IN13Q4 20189.7%
CATALYST PHARM PARTNERS INC13Q3 20199.4%

View Consonance Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Consonance Capital Management LP Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Surrozen, Inc./DESold outDecember 15, 202200.0%
ADMA BIOLOGICS, INC.February 14, 20221,289,4811.4%
ASSEMBLY BIOSCIENCES, INC.Sold outFebruary 14, 202200.0%
CASI Pharmaceuticals, Inc.Sold outFebruary 14, 202200.0%
Cellectar Biosciences, Inc.Sold outFebruary 14, 202200.0%
Gamida Cell Ltd.Sold outFebruary 14, 202200.0%
GenMark Diagnostics, Inc.Sold outFebruary 14, 202200.0%
Protagonist Therapeutics, IncSold outFebruary 14, 202200.0%
Sio Gene Therapies Inc.Sold outFebruary 14, 202200.0%
Consonance-HFW Acquisition Corp.April 27, 20211,000,00010.4%

View Consonance Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
42022-12-15
SC 13D/A2022-12-15
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
SC 13G/A2022-02-14
SC 13G/A2022-02-14
SC 13G/A2022-02-14
SC 13G/A2022-02-14

View Consonance Capital Management LP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export Consonance Capital Management LP's holdings

CSVXLS